Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Compromised genomic integrity impedes muscle growth after Atrx inactivation.

Huh MS, Price O'Dea T, Ouazia D, McKay BC, Parise G, Parks RJ, Rudnicki MA, Picketts DJ.

J Clin Invest. 2012 Dec;122(12):4412-23. doi: 10.1172/JCI63765. Epub 2012 Nov 1.

2.

Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome.

Bagheri-Fam S, Argentaro A, Svingen T, Combes AN, Sinclair AH, Koopman P, Harley VR.

Hum Mol Genet. 2011 Jun 1;20(11):2213-24. doi: 10.1093/hmg/ddr109. Epub 2011 Mar 22. Erratum in: Hum Mol Genet. 2011 Sep 1;20(17):3535.

3.

ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.

Wong LH, McGhie JD, Sim M, Anderson MA, Ahn S, Hannan RD, George AJ, Morgan KA, Mann JR, Choo KH.

Genome Res. 2010 Mar;20(3):351-60. doi: 10.1101/gr.101477.109. Epub 2010 Jan 28.

4.

ATRX has a critical and conserved role in mammalian sexual differentiation.

Huyhn K, Renfree MB, Graves JA, Pask AJ.

BMC Dev Biol. 2011 Jun 14;11:39. doi: 10.1186/1471-213X-11-39.

5.

Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress.

Leung JW, Ghosal G, Wang W, Shen X, Wang J, Li L, Chen J.

J Biol Chem. 2013 Mar 1;288(9):6342-50. doi: 10.1074/jbc.M112.411603. Epub 2013 Jan 16.

6.

The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.

Bérubé NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ, Higgs DR, Slack RS, Picketts DJ.

J Clin Invest. 2005 Feb;115(2):258-67.

7.

[X-linked alpha-thalassemia/mental retardation syndrome].

Wada T.

Rinsho Byori. 2009 Apr;57(4):382-90. Review. Japanese.

PMID:
19489441
8.

Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.

De La Fuente R, Baumann C, Viveiros MM.

Reproduction. 2011 Aug;142(2):221-34. doi: 10.1530/REP-10-0380. Epub 2011 Jun 8. Review.

9.

The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.

Dhayalan A, Tamas R, Bock I, Tattermusch A, Dimitrova E, Kudithipudi S, Ragozin S, Jeltsch A.

Hum Mol Genet. 2011 Jun 1;20(11):2195-203. doi: 10.1093/hmg/ddr107. Epub 2011 Mar 18.

10.

ATRX in chromatin assembly and genome architecture during development and disease.

Bérubé NG.

Biochem Cell Biol. 2011 Oct;89(5):435-44. doi: 10.1139/o11-038. Epub 2011 Aug 18.

PMID:
21851155
11.

ATR and H2AX cooperate in maintaining genome stability under replication stress.

Chanoux RA, Yin B, Urtishak KA, Asare A, Bassing CH, Brown EJ.

J Biol Chem. 2009 Feb 27;284(9):5994-6003. doi: 10.1074/jbc.M806739200. Epub 2008 Dec 2.

12.

ATRX and the replication of structured DNA.

Clynes D, Gibbons RJ.

Curr Opin Genet Dev. 2013 Jun;23(3):289-94. doi: 10.1016/j.gde.2013.01.005. Epub 2013 Feb 28. Review.

PMID:
23453691
13.

ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain.

Kernohan KD, Jiang Y, Tremblay DC, Bonvissuto AC, Eubanks JH, Mann MR, Bérubé NG.

Dev Cell. 2010 Feb 16;18(2):191-202. doi: 10.1016/j.devcel.2009.12.017.

14.

ATRX promotes gene expression by facilitating transcriptional elongation through guanine-rich coding regions.

Levy MA, Kernohan KD, Jiang Y, Bérubé NG.

Hum Mol Genet. 2015 Apr 1;24(7):1824-35. doi: 10.1093/hmg/ddu596. Epub 2014 Dec 1.

15.

Patient mutations alter ATRX targeting to PML nuclear bodies.

Bérubé NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M, Picketts DJ.

Eur J Hum Genet. 2008 Feb;16(2):192-201. Epub 2007 Oct 24.

16.

ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression.

Ratnakumar K, Duarte LF, LeRoy G, Hasson D, Smeets D, Vardabasso C, Bönisch C, Zeng T, Xiang B, Zhang DY, Li H, Wang X, Hake SB, Schermelleh L, Garcia BA, Bernstein E.

Genes Dev. 2012 Mar 1;26(5):433-8. doi: 10.1101/gad.179416.111.

17.

Loss of Atrx sensitizes cells to DNA damaging agents through p53-mediated death pathways.

Conte D, Huh M, Goodall E, Delorme M, Parks RJ, Picketts DJ.

PLoS One. 2012;7(12):e52167. doi: 10.1371/journal.pone.0052167. Epub 2012 Dec 17.

18.

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.

Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, Rosenbluh J, Zwang Y, Weir BA, Hatton C, Ivanova E, Macconaill L, Hanna M, Hahn WC, Lue NF, Reddel RR, Jiao Y, Kinzler K, Vogelstein B, Papadopoulos N, Meeker AK; ALT Starr Cancer Consortium.

PLoS Genet. 2012;8(7):e1002772. Epub 2012 Jul 19.

19.

Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly.

Solomon LA, Russell BA, Watson LA, Beier F, Bérubé NG.

Hum Mol Genet. 2013 Dec 15;22(24):5015-25. doi: 10.1093/hmg/ddt351. Epub 2013 Jul 25.

20.
Items per page

Supplemental Content

Write to the Help Desk